Ondansetron enhanced diclofenac-induced nephrotoxicity in mice

J Biochem Mol Toxicol. 2019 Sep;33(9):e22378. doi: 10.1002/jbt.22378. Epub 2019 Jul 23.

Abstract

This study was performed to investigate the effect of ondansetron, a serotonin receptor (5-HT3) antagonist, in the alleviation of diclofenac-induced kidney injuries. NMRI mice were randomly divided into six groups and treated with (A) untreated control group, (B) diclofenac (100 mg/kg), (C) ondansetron (1 mg/kg), (D to F) ondansetron (0.1, 0.5, and 1 mg/kg, respectively) and diclofenac (100 mg/kg) for last 3 days of experiment. The oxidative stress tests strongly demonstrated the negative synergistic effects of diclofenac and ondansetron, regarding the observation of dose-dependent enhancement of malondialdehyde concentration, and reduction of glutathione content, and superoxide dismutase and catalase activity. Histopathological analyses revealed dose-dependent tubular epithelial cells degeneration, outstanding mononuclear cells infiltration, clear necrosis at the papillary region of kidney, dilation, and vascular hyperemia in mice kidney tissues treated with ondansetron and diclofenac. Conclusively, these findings suggested the possible ondansetron-diclofenac interaction through the induction of oxidative stress.

Keywords: interaction; kidney; oxidative stress; serotonin receptor.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / toxicity*
  • Catalase / metabolism
  • Diclofenac / toxicity*
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Glutathione / metabolism
  • Kidney / drug effects*
  • Kidney / pathology
  • Mice
  • Ondansetron / administration & dosage
  • Ondansetron / pharmacology*
  • Serotonin Antagonists / administration & dosage
  • Serotonin Antagonists / pharmacology*
  • Superoxide Dismutase / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Serotonin Antagonists
  • Diclofenac
  • Ondansetron
  • Catalase
  • Superoxide Dismutase
  • Glutathione